HEALTHCROSSCUT SEATTLE
Research shows weight-loss drugs may also reduce cancer risk
Research suggests weight-loss drugs like Ozempic and Wegovy may help treat or prevent certain cancers. These drugs, part of the GLP-1 class, are now used by one-in-eight American adults.
Related Signal
Adjacent reporting
- GLP-1 weight-loss drugs might help protect against breast cancer, study presented at ASCO meeting suggests
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests
- GLP-1 drugs linked to reduced cancer risk, researchers say
- Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
- Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study